Tacrolimus After rATG and Infliximab Induction Immunosuppression-RIMINI Trial.

Ondrej Viklicky,Ivan Zahradka,Gantuja Bold,Oriol Bestard,Petra Hruba,Natalie M Otto,Maik Stein,Anett Sefrin,Istvan Modos,Maria Meneghini,Elena Crespo,Josep Grinyo,Hans-Dieter Volk,Sofia Christakoudi,Petra Reinke

Transplantation（2023）

引用 0|浏览14

暂无评分

摘要

A similar efficacy of the study immunosuppression regimen to the comparator study and the historical matched cohort was found. However, a higher de novo DSA emergence points to an increased risk of antibody-mediated rejection (NCT04114188).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要